Evolv Technologies Holdings, Inc.

NasdaqCM:EVLV Aktierapport

Börsvärde: US$1.0b

Evolv Technologies Holdings Balansräkning Hälsa

Finansiell hälsa kriterier kontrolleras 6/6

Evolv Technologies Holdings har ett totalt eget kapital på $120.7M och en total skuld på $28.7M vilket ger sin skuldsättningsgrad till 23.8%. Dess totala tillgångar och totala skulder är $304.6M respektive $184.0M.

Viktig information

23.75%

Skuldsättning i förhållande till eget kapital

US$28.67m

Skuld

Räntetäckningsgradn/a
KontanterUS$61.07m
Eget kapitalUS$120.67m
Summa skulderUS$183.97m
Totala tillgångarUS$304.64m

Nya uppdateringar om finansiell hälsa

Analysartikel Jan 23

Here's Why We're Not At All Concerned With Evolv Technologies Holdings' (NASDAQ:EVLV) Cash Burn Situation

Just because a business does not make any money, does not mean that the stock will go down. For example, although...

Recent updates

Uppdatering av berättelse May 02

EVLV: Raised 2026 Guidance And Venue Wins Will Support Future Upside

Analysts have raised their fair value estimate for Evolv Technologies Holdings from $9.50 to $10.00, citing updated assumptions around discount rates, revenue growth, profit margins, and a higher future P/E multiple as key drivers of the new price target. What's in the News Evolv raised its 2026 revenue guidance to a range of US$172 million to US$178 million, compared with prior guidance of US$160 million to US$165 million, following an Analyst and Investor Day focused on vision, strategy, growth initiatives, products, technology and financial goals.
Uppdatering av berättelse Apr 18

EVLV: Stadium And Hospital Security Contracts Will Drive Multi Year Upside

Analysts have adjusted their price target on Evolv Technologies Holdings to $10.50. The change reflects updated assumptions around discount rate, revenue growth, profit margin and future P/E, rather than a shift in fair value.
Uppdatering av berättelse Apr 03

EVLV: Expanding Stadium And Hospital Contracts Will Drive Long Term Upside

Analysts have modestly adjusted their price target on Evolv Technologies Holdings, keeping fair value at $9.50 while fine tuning assumptions around the discount rate, revenue growth, profit margin, and future P/E to reflect updated views on the company’s risk profile and long term earnings potential. What's in the News Evolv renewed and expanded its subscription agreement with the Houston Astros, upgrading the venue wide deployment at 41,000 seat Daikin Park to Express Gen2 hardware and adding eXpedite bag screening for staff, which brings Evolv’s professional baseball customer count to twelve.
Uppdatering av berättelse Mar 20

EVLV: Expanded Stadium And Hospital Contracts Will Support Multi Year Upside

Analysts have nudged their price target for Evolv Technologies Holdings up from $10.00 to $10.50. They point to updated assumptions around slightly higher revenue growth, a marginally lower discount rate, and a modestly lower future P/E as key drivers of the change.
Uppdatering av berättelse Mar 06

EVLV: Expanding Stadium And Healthcare Contracts Will Support Bullish Multi Year Upside

Analysts have adjusted their price target on Evolv Technologies Holdings to $10.00, with the change linked to updated assumptions around revenue growth, profit margins and the future P/E multiple, even though the headline fair value figure remains stated at $10.00. What's in the News Evolv extended and expanded its multi year hardware and software subscription with Bank of America Stadium in Charlotte, upgrading nearly twenty Evolv Express systems to Gen2 hardware and adding eXpedite bag screening ahead of the March 7, 2026 Charlotte FC home opener (Client announcement).
Uppdatering av berättelse Feb 20

EVLV: Venue Partnerships Will Set Up A Breakout Year In 2026

Analysts have adjusted their price targets for Evolv Technologies Holdings slightly, reflecting updated assumptions around discount rates, revenue growth of about 17.85%, profit margins near 8.19%, and a future P/E of roughly 139.15x. These inputs support a refined view of fair value that remains around $9.50 per share.
Uppdatering av berättelse Feb 05

EVLV: Q3 Outperformance And 2026 ARR Focus Will Support Bullish Case

Analysts lifted their price target on Evolv Technologies Holdings to US$10 from US$9, citing recent quarterly performance and expectations that annual recurring revenue growth could outpace revenue growth by 2026. Analyst Commentary Recent commentary from bullish analysts centers on a higher conviction view of Evolv Technologies Holdings after its latest quarterly report, with particular attention on the relationship between annual recurring revenue and total revenue over the medium term.
Uppdatering av berättelse Jan 22

EVLV: ARR Momentum Will Set Up A Breakout Year In 2026

Narrative Update on Evolv Technologies Holdings Analysts have raised their price target on Evolv Technologies Holdings to $10 from $9, citing a recent quarterly performance described as a strong beat and noting expectations that by 2026 annual recurring revenue growth could exceed reported revenue growth. Analyst Commentary The latest price target change to US$10 highlights that some on the Street see upside potential, but even supportive research comes with clear caveats around how the story could play out over the next few years.
Uppdatering av berättelse Jan 08

EVLV: Q3 Beat And 2026 ARR Breakout Potential Support Bullish Outlook

Analysts have raised their fair value estimate for Evolv Technologies Holdings to $10.00 from $8.25 after a Q3 performance that they describe as very strong, and based on expectations that annual recurring revenue growth could outpace overall revenue growth by 2026. Analyst Commentary Bullish analysts are pointing to Evolv Technologies Holdings' Q3 performance as a key support for higher valuation expectations, with recent fair value and price target increases signaling growing confidence in the company’s execution.
Uppdatering av berättelse Dec 14

EVLV: ARR Momentum Will Drive A Breakout Year In 2026

Analysts lifted their price target on Evolv Technologies Holdings by $1 to $10, citing a substantial Q3 beat and expectations that accelerating ARR growth will position 2026 as a breakout year. Analyst Commentary While the latest price target increase to $10 reflects optimism around Evolv Technologies Holdings' Q3 performance and medium term growth prospects, not all market observers are uniformly bullish.
Uppdatering av berättelse Aug 16

Multi-Year Contracts With Public Schools And Hospitals Will Expand Markets

The analyst price target for Evolv Technologies Holdings has been raised significantly, driven by a Q2 earnings beat, upgraded FY25 revenue guidance, improved business outlook following regulatory clarity and management changes, as well as momentum across key industry verticals, lifting the consensus fair value from $7.19 to $9.50. Analyst Commentary Q2 earnings beat on both revenue and AEBITDA, leading to upgraded financial forecasts for FY25.
User avatar
Ny berättelse Jun 01

AI Screening Will Expand Public Safety Applications

Heightened demand for advanced security and regulatory mandates drive strong growth potential for recurring subscription revenue across diverse markets.
Analysartikel May 21

The Price Is Right For Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) Even After Diving 28%

Unfortunately for some shareholders, the Evolv Technologies Holdings, Inc. ( NASDAQ:EVLV ) share price has dived 28% in...
Analysartikel Feb 16

After Leaping 29% Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) Shares Are Not Flying Under The Radar

The Evolv Technologies Holdings, Inc. ( NASDAQ:EVLV ) share price has done very well over the last month, posting an...
Analysartikel Jan 23

Here's Why We're Not At All Concerned With Evolv Technologies Holdings' (NASDAQ:EVLV) Cash Burn Situation

Just because a business does not make any money, does not mean that the stock will go down. For example, although...
Analysartikel Dec 14

After Leaping 33% Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) Shares Are Not Flying Under The Radar

Evolv Technologies Holdings, Inc. ( NASDAQ:EVLV ) shareholders are no doubt pleased to see that the share price has...

Analys av finansiell ställning

Kortfristiga skulder: EVLV s kortfristiga tillgångar ( $152.0M ) överstiger dess kortfristiga skulder ( $125.9M ).

Långfristiga skulder: EVLV s kortfristiga tillgångar ( $152.0M ) överstiger dess långfristiga skulder ( $58.1M ).


Skuld till eget kapital Historik och analys

Skuldnivå: EVLV har mer kontanter än sin totala skuld.

Minska skulden: EVLV hade negativt eget kapital för 5 år sedan, men är nu positivt och har därför förbättrats.


Balansräkning


Analys av kontantbanan

För företag som i genomsnitt har gått med förlust tidigare bedömer vi om de har minst 1 års kassaflöde.

Stabil Cash Runway: EVLV har tillräckligt med cash runway i mer än 3 år baserat på dess nuvarande fria kassaflöde.

Prognos Cash Runway: EVLV har tillräckligt med kontanter under 1.3 år om det fria kassaflödet fortsätter att växa i historiska takter på 8 % varje år


Upptäck friska företag

Företagsanalys och finansiella data Status

UppgifterSenast uppdaterad (UTC-tid)
Analys av företag2026/05/20 04:20
Aktiekurs vid dagens slut2026/05/20 00:00
Intäkter2026/03/31
Årlig intjäning2025/12/31

Datakällor

Den data som används i vår företagsanalys kommer från S&P Global Market Intelligence LLC. Följande data används i vår analysmodell för att generera denna rapport. Data är normaliserade vilket kan medföra en fördröjning från det att källan är tillgänglig.

PaketUppgifterTidsramExempel US-källa
Företagets finansiella ställning10 år
  • Resultaträkning
  • Kassaflödesanalys
  • Balansräkning
Analytikernas konsensusuppskattningar+3 år
  • Prognos för finansiella poster
  • Analytikernas prismål
Marknadspriser30 år
  • Aktiekurser
  • Utdelningar, splittar och åtgärder
Ägarskap10 år
  • Största aktieägare
  • Insiderhandel
Förvaltning10 år
  • Ledningsgrupp
  • Styrelse och verkställande direktörer
Viktiga utvecklingstendenser10 år
  • Företagsmeddelanden

* Exempel för amerikanska värdepapper, för icke-amerikanska värdepapper används motsvarande regelverk och källor.

Om inget annat anges är all finansiell data baserad på en årsperiod men uppdateras kvartalsvis. Detta kallas data för efterföljande tolv månader (TTM) eller senaste tolv månader (LTM). Lär dig mer om detta.

Analysmodell och snöflinga

Detaljer om analysmodellen som användes för att skapa den här rapporten finns på vår Github-sida, vi har också guider om hur du använder våra rapporter och tutorials på Youtube.

Lär dig mer om det team i världsklass som utformade och byggde analysmodellen Simply Wall St.

Industri- och sektormått

Våra bransch- och sektionsmått beräknas var sjätte timme av Simply Wall St, detaljer om vår process finns tillgängliga på Github.

Källor för analytiker

Evolv Technologies Holdings, Inc. bevakas av 5 analytiker. 4 av dessa analytiker lämnade de uppskattningar av intäkter eller resultat som användes som indata till vår rapport. Analytikernas inskickade estimat uppdateras löpande under dagen.

AnalytikerInstitution
Jeremy HamblinCraig-Hallum Capital Group LLC
Eric MartinuzziLake Street Capital Markets, LLC
Michael LatimoreNorthland Capital Markets